Healthcare - Biotechnology - NASDAQ - US
$ 3.85
-1.79 %
$ 414 M
Market Cap
-3.35
P/E
Price Target
Average
280.95%
Revenue Forecast
Estimate
--1.29%
EBIT
Estimate
27.23%
Net Income
Estimate
--6.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Tango Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for TNGX of $14.7 , with forecasts ranging from a low of $13 to a high of $18 .
TNGX Lowest Price Target
Wall Street Target
13 USD
237.66%
TNGX Average Price Target
Wall Street Target
14.7 USD
280.95%
TNGX Highest Price Target
Wall Street Target
18 USD
367.53%
REVENUE FORECAST
Revenue Forecast Chart TNGX
EBIT FORECAST
EBIT Forecast Chart TNGX
NET INCOME FORECAST
Net Income Chart TNGX